Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Trial Phase 3 Active, not recruiting April 16, 2026

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

Trial N/A Recruiting April 16, 2026

First-in-Human Single and Multiple Dose of HL-400

Trial Phase 1 Recruiting April 16, 2026

The Swedish BioFINDER Sleep Study

Trial N/A Recruiting April 15, 2026

Phase 2a Study of VTX3232 in Parkinson's Disease

Trial Phase 2 Completed April 14, 2026

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

Trial Phase 2 Completed April 14, 2026

Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation

Trial N/A Recruiting April 14, 2026

Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study

Trial N/A Not yet recruiting April 14, 2026

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

Trial Phase 2 Active, not recruiting April 14, 2026

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

Trial Phase 1 Recruiting April 13, 2026

Ketamine for Veterans With Parkinson's Disease

Trial Phase 2 Recruiting April 12, 2026

Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease

Trial N/A Recruiting April 12, 2026

Genotypic Influences on Network Progression in Parkinson's Disease

Trial N/A Active, not recruiting April 12, 2026

Neuroimaging of Parkinson's

Trial N/A Recruiting April 12, 2026

Dance and Energy Expenditure Among Adults With Parkinson's

Trial N/A Recruiting April 12, 2026

Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study

Trial N/A Available April 12, 2026

Rostock International Parkinson's Disease Study (ROPAD)

Trial N/A Completed April 12, 2026

Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients

Trial Phase 1 Completed April 12, 2026

Effects of Stimulation Patterns of Deep Brain Stimulation

Trial N/A Enrolling by invitation April 8, 2026

Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

Trial N/A Enrolling by invitation April 8, 2026